Versor Investments LP Bionano Genomics, Inc. Transaction History

Versor Investments LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$1.4 - $25.4 $85,292 - $1.55 Million	-60,923 Reduced 50.67%	59,300 $86,000
Q3 2022 Oct 25, 2022	SELL	$0.36 - $36.0 $6,219 - $621,972	-17,277 Reduced 12.57%	120,223 $220,000
Q2 2022 Jul 27, 2022	BUY	$12.3 - $27.3 $1.19 Million - $2.65 Million	97,091 Added 240.27%	137,500 $190,000
Q1 2022 May 04, 2022	SELL	$16.6 - $32.3 $614,200 - $1.2 Million	-37,000 Reduced 47.8%	40,409 $104,000
Q4 2021 Feb 08, 2022	BUY	$29.9 - $61.2 $2.31 Million - $4.74 Million	77,409 New	77,409 $231,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.